Physician profile
Heather R Haley
NPI 1063493716
$13,605.87
in general payments reported to CMS, 2019-2025
51 companies · $1,711 in 2025
The $1,711 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,134 · 2020: $1,478 · 2021: $1,860 · 2022: $1,826 · 2023: $2,413 · 2024: $2,184 · 2025: $1,711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,085 · Education: $211 · Travel and Lodging: $12.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,084.77 |
| Education | $210.97 |
| Travel and Lodging | $12.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,966.30 | 2019-2025 | |
| Allergan, INC. | $2,266.64 | 2019-2022 | |
| Hill Dermaceuticals, INC. | $779.95 | 2023-2024 | Tolak |
| Sun Pharmaceutical Industries INC. | $772.78 | 2020-2025 | Ilumya, Blu-U, Winlevi |
| Novartis Pharmaceuticals Corporation | $607.33 | 2019-2025 | |
| Galderma Laboratories, L.P. | $584.52 | 2019-2025 | Dysport, Nemluvio, Aklief |
| Incyte Corporation | $563.56 | 2021-2025 | Opzelura |
| Janssen Biotech, INC. | $547.10 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Pfizer INC. | $478.05 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $353.26 | 2023-2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $312.38 | 2019-2024 | Arazlo, Cabtreo, Jublia |
| Ucb, INC. | $287.12 | 2019-2025 | Bimzelx |
| Leo Pharma INC. | $278.43 | 2019-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $250.44 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $227.66 | 2019-2023 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Haley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.